Skip to main content
American Journal of Respiratory and Critical Care Medicine logoLink to American Journal of Respiratory and Critical Care Medicine
letter
. 2020 Jan 1;201(1):119–120. doi: 10.1164/rccm.201907-1394LE

Video Teleheath and Pulmonary Rehabilitation: Need for a Better Understanding

Sébastien Gagnon 1,*, Bryan Ross 1, Jean Bourbeau 1,2
PMCID: PMC6938153  PMID: 31386815

To the Editor:

We read with great interest the recent article by Bhatt and colleagues (1). As mentioned by the authors, there is clearly a pressing need for a solution to the high rate of 30-day readmissions after hospitalization for an acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Despite the effectiveness demonstrated by early pulmonary rehabilitation (PR) after AECOPD, there have been poor uptake, adherence, and completion rates for various reasons (24).

In this context, telehealth medicine has been proposed as an interesting solution, with the potential to broaden and facilitate access to PR, thereby possibly resulting in lower overall rates of hospital readmission after AECOPD. To address this question, Bhatt and colleagues compared a prospective group of patients participating in a video telehealth PR program (administered via smartphone) with a retrospective contemporaneous cohort who received comprehensive bundled care after hospital discharge. The primary outcome was the 30-day all-cause readmission rate. The results are impressive, with a 30-day absolute reduction in all-cause and AECOPD readmissions of 11.9% and 8.1%, respectively. These results are very appealing, but they should be interpreted with caution. First, the authors do not include patient acceptance or refusal data or overall patient participation rates. Another limitation of this study is related to the design, as this was not a randomized clinical trial. Despite efforts made to match the two groups, the significantly higher proportion of patients on domiciliary oxygen in the intervention group is concerning. This difference may have contributed to the observed improvement in the treatment group if, for example, more attention and closer follow-up was provided to these patients.

Furthermore, the methodological description of the video telehealth PR intervention was insufficient. Information on supervising roles and personnel during the telehealth sessions, or in personalizing exercise prescriptions during individual sessions, is critical to understanding this intervention. From a knowledge translation perspective, replication and wider dissemination of this intervention will require a more detailed description of its content and how it was administered.

Another aspect to question is the speed at which PR could realistically impact the 30-day hospital admission rate. Patients who received the intervention only started the telehealth PR program at the follow-up visit, which was 10 ± 2 days after discharge. Consequently, the effect of the intervention, evaluated at 30 days after discharge, would be measured after a maximal period of 22 days of active intervention.

Beyond the physical training component, support by healthcare professionals and behavioral change could have also had a significant impact on patient outcomes. To better understand the intervention, it would be important to know about the content and the delivery of the educational sessions and if patients had integrated specific behaviors or coping strategies into their daily life. The production of an effective new behavioral change intervention involves a progressive and meticulous process, such as that suggested by the ORBIT (Obesity-Related Behavioral Intervention Trials) model (5). This model was created after the negative results of a large-scale trial evaluating behavioral intervention, the Look AHEAD (Action for Health in Diabetes) trial (6). Just like in pharmaceutical development, behavioral change intervention development should evolve through a phase process that includes, among others, design, defining and refining the intervention, proof-of-concept, and pilot study. This process encourages a rigorous translation from idea to practice and avoids large expenses in inefficient interventions.

The results reported by Bhatt and colleagues (1) are surely interesting, and video telehealth could well be an acceptable, efficient, and effective way of delivering PR in the future. However, until we are better able to define the specific components and delivery of this intervention and its effect on patient coping strategies, the role of PR via video telehealth remains to be answered.

Supplementary Material

Supplements
Author disclosures

Footnotes

Originally Published in Press as DOI: 10.1164/rccm.201907-1394LE on August 6, 2019

Author disclosures are available with the text of this letter at www.atsjournals.org.

References

  • 1.Bhatt SP, Patel SB, Anderson EM, Baugh D, Givens T, Schumann C, et al. Video telehealth pulmonary rehabilitation intervention in COPD reduces 30-day readmissions. Am J Respir Crit Care Med. doi: 10.1164/rccm.201902-0314LE. [online ahead of print] 12 Apr 2019; DOI: 10.1164/rccm.201902-0314LE. Published in final form as Am J Respir Crit Care Med 2019;200:511–513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Criner GJ, Bourbeau J, Diekemper RL, Ouellette DR, Goodridge D, Hernandez P, et al. Executive summary: prevention of acute exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest. 2015;147:883–893. doi: 10.1378/chest.14-1677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Harrison SL, Robertson N, Graham CD, Williams J, Steiner MC, Morgan MD, et al. Can we identify patients with different illness schema following an acute exacerbation of COPD: a cluster analysis. Respir Med. 2014;108:319–328. doi: 10.1016/j.rmed.2013.10.016. [DOI] [PubMed] [Google Scholar]
  • 4.Man WD, Puhan MA, Harrison SL, Jordan RE, Quint JK, Singh SJ.Pulmonary rehabilitation and severe exacerbations of COPD: solution or white elephant? ERJ Open Res 2015100050–2015.. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Czajkowski SM, Powell LH, Adler N, Naar-King S, Reynolds KD, Hunter CM, et al. From ideas to efficacy: the ORBIT model for developing behavioral treatments for chronic diseases. Health Psychol. 2015;34:971–982. doi: 10.1037/hea0000161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, Coday M, et al. Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145–154. doi: 10.1056/NEJMoa1212914. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplements
Author disclosures

Articles from American Journal of Respiratory and Critical Care Medicine are provided here courtesy of American Thoracic Society

RESOURCES